Published in Clin Vaccine Immunol on August 08, 2007
The biological basis of severe outcomes in Anaplasma phagocytophilum infection. FEMS Immunol Med Microbiol (2011) 1.09
Gene expression profile suggests that pigs (Sus scrofa) are susceptible to Anaplasma phagocytophilum but control infection. Parasit Vectors (2012) 1.07
Anaplasma phagocytophilum: deceptively simple or simply deceptive? Future Microbiol (2012) 0.96
Dexamethasone-induced cytokine changes associated with diminished disease severity in horses infected with Anaplasma phagocytophilum. Clin Vaccine Immunol (2011) 0.89
Sequential analysis of Anaplasma phagocytophilum msp2 transcription in murine and equine models of human granulocytic anaplasmosis. Clin Vaccine Immunol (2007) 0.88
Anaplasma phagocytophilum, interferon gamma production and Stat1 signaling. Microbiol Immunol (2013) 0.78
Infection-derived lipids elicit an immune deficiency circuit in arthropods. Nat Commun (2017) 0.77
Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature (2005) 7.72
Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol (2006) 5.51
Human granulocytic anaplasmosis and Anaplasma phagocytophilum. Emerg Infect Dis (2005) 3.90
Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc Natl Acad Sci U S A (2004) 2.49
Ehrlichia chaffeensis and Anaplasma phagocytophilum lack genes for lipid A biosynthesis and incorporate cholesterol for their survival. Infect Immun (2003) 2.37
CD4(+) T-lymphocyte and immunoglobulin G2 responses in calves immunized with Anaplasma marginale outer membranes and protected against homologous challenge. Infect Immun (1998) 1.76
Comparative pathology, and immunohistology associated with clinical illness after Ehrlichia phagocytophila-group infections. Am J Trop Med Hyg (2000) 1.55
Pathology, immunohistology, and cytokine responses in early phases of human granulocytic ehrlichiosis in a murine model. J Infect Dis (2000) 1.43
Immunopathology and ehrlichial propagation are regulated by interferon-gamma and interleukin-10 in a murine model of human granulocytic ehrlichiosis. Am J Pathol (2001) 1.42
Granulocytic ehrlichiosis in the laboratory mouse. J Infect Dis (1998) 1.37
Exploitation of interleukin-8-induced neutrophil chemotaxis by the agent of human granulocytic ehrlichiosis. Infect Immun (2001) 1.36
Isolation of glycosphingolipids. Methods Enzymol (1994) 1.23
Diminished adhesion of Anaplasma phagocytophilum-infected neutrophils to endothelial cells is associated with reduced expression of leukocyte surface selectin. Infect Immun (2003) 1.20
CXCR2 blockade influences Anaplasma phagocytophilum propagation but not histopathology in the mouse model of human granulocytic anaplasmosis. Clin Diagn Lab Immunol (2004) 1.20
Development and distribution of pathologic lesions are related to immune status and tissue deposition of human granulocytic ehrlichiosis agent-infected cells in a murine model system. J Infect Dis (1999) 1.18
Experimental transmission of Ehrlichia equi to horses through naturally infected ticks (Ixodes pacificus) from Northern California. J Clin Microbiol (1998) 1.14
Anaplasma phagocytophilum ligation to toll-like receptor (TLR) 2, but not to TLR4, activates macrophages for nuclear factor-kappa B nuclear translocation. J Infect Dis (2004) 1.06
Anaplasma phagocytophilum infection induces protracted neutrophil degranulation. Infect Immun (2004) 1.04
Experimental inoculation with human granulocytic Ehrlichia agent derived from high- and low-passage cell culture in horses. J Clin Microbiol (2000) 0.98
Human anaplasmosis presenting as atypical pneumonitis in France. Clin Infect Dis (2003) 0.94
Differential innate immune cell activation and proinflammatory response in Anaplasma phagocytophilum infection. Infect Immun (2007) 0.92
Innate immune response to Anaplasma phagocytophilum contributes to hepatic injury. Clin Vaccine Immunol (2006) 0.92
Msp2 variation in Anaplasma phagocytophilum in vivo does not stimulate T cell immune responses or interferon-gamma production. FEMS Immunol Med Microbiol (2007) 0.92
Role of reactive nitrogen species in development of hepatic injury in a C57bl/6 mouse model of human granulocytic anaplasmosis. Comp Med (2006) 0.91
Ehrlichia infection as a cause of severe respiratory distress. N Engl J Med (1996) 0.90
Innate immune tissue injury and murine HGA: tissue injury in the murine model of granulocytic anaplasmosis relates to host innate immune response and not pathogen load. Ann N Y Acad Sci (2005) 0.86
Measurement of lymphocyte proliferation: critical analysis of radioactive and photometric methods. Immunobiology (1992) 0.83
Ehrlichiosis with pancytopenia and ARDS. N J Med (1995) 0.81
NKT cells-containing inflammatory lesions induced by Yersinia pseudotuberculosis glycolipids. Immunol Lett (2002) 0.77
The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis (2006) 13.01
Nosocomial transmission of human granulocytic anaplasmosis in China. JAMA (2008) 5.01
Gene sequence-based criteria for identification of new rickettsia isolates and description of Rickettsia heilongjiangensis sp. nov. J Clin Microbiol (2003) 3.59
Antiscience and ethical concerns associated with advocacy of Lyme disease. Lancet Infect Dis (2011) 2.88
Anaplasma phagocytophilum AnkA binds to granulocyte DNA and nuclear proteins. Cell Microbiol (2004) 1.87
Distinct host species correlate with Anaplasma phagocytophilum ankA gene clusters. J Clin Microbiol (2010) 1.52
Silencing of host cell CYBB gene expression by the nuclear effector AnkA of the intracellular pathogen Anaplasma phagocytophilum. Infect Immun (2009) 1.51
Clinical diagnosis and treatment of human granulocytotropic anaplasmosis. Ann N Y Acad Sci (2006) 1.48
Borrelia burgdorferi ospC heterogeneity among human and murine isolates from a defined region of northern Maryland and southern Pennsylvania: lack of correlation with invasive and noninvasive genotypes. J Clin Microbiol (2005) 1.46
Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease. Diagn Microbiol Infect Dis (2012) 1.45
Neorickettsia helminthoeca and salmon poisoning disease: a review. Vet J (2009) 1.45
Single-dose prophylaxis against Lyme disease. Lancet Infect Dis (2007) 1.45
Current management of human granulocytic anaplasmosis, human monocytic ehrlichiosis and Ehrlichia ewingii ehrlichiosis. Expert Rev Anti Infect Ther (2009) 1.33
Emerging and re-emerging tick-transmitted rickettsial and ehrlichial infections. Med Clin North Am (2008) 1.31
Major surface protein 2 of Anaplasma phagocytophilum facilitates adherence to granulocytes. Infect Immun (2003) 1.29
Epigenetic silencing of host cell defense genes enhances intracellular survival of the rickettsial pathogen Anaplasma phagocytophilum. PLoS Pathog (2009) 1.28
The history of epidemic typhus. Infect Dis Clin North Am (2004) 1.27
Prevalence and density-related concordance of three diagnostic tests for malaria in a region of Tanzania with hypoendemic malaria. J Clin Microbiol (2011) 1.25
Anaplasma phagocytophilum from Rodents and Sheep, China. Emerg Infect Dis (2010) 1.22
Serologic and molecular detection of Ehrlichia chaffeensis and Anaplasma phagocytophila (human granulocytic ehrlichiosis agent) in Korean patients. J Clin Microbiol (2002) 1.22
Two-year evaluation of Borrelia burgdorferi culture and supplemental tests for definitive diagnosis of Lyme disease. J Clin Microbiol (2005) 1.21
Diminished adhesion of Anaplasma phagocytophilum-infected neutrophils to endothelial cells is associated with reduced expression of leukocyte surface selectin. Infect Immun (2003) 1.20
CXCR2 blockade influences Anaplasma phagocytophilum propagation but not histopathology in the mouse model of human granulocytic anaplasmosis. Clin Diagn Lab Immunol (2004) 1.20
Leptospirosis as frequent cause of acute febrile illness in southern Sri Lanka. Emerg Infect Dis (2011) 1.17
Borrelia burgdorferi, host-derived proteases, and the blood-brain barrier. Infect Immun (2005) 1.17
Cardiac valves in patients with Whipple endocarditis: microbiological, molecular, quantitative histologic, and immunohistochemical studies of 5 patients. J Infect Dis (2004) 1.16
Restricted changes in major surface protein-2 (msp2) transcription after prolonged in vitro passage of Anaplasma phagocytophilum. BMC Microbiol (2004) 1.14
Human monocytic ehrlichiosis presenting as acute appendicitis during pregnancy. Clin Infect Dis (2002) 1.10
Anaplasma phagocytophilum delay of neutrophil apoptosis through the p38 mitogen-activated protein kinase signal pathway. Infect Immun (2005) 1.09
Detection of antibodies to Anaplasma phagocytophilum and Ehrlichia chaffeensis antigens in sera of Korean patients by western immunoblotting and indirect immunofluorescence assays. Clin Diagn Lab Immunol (2003) 1.09
Genetic variability and stability of Anaplasma phagocytophila msp2 (p44). Infect Immun (2002) 1.08
Rickettsial Seroepidemiology among farm workers, Tianjin, People's Republic of China. Emerg Infect Dis (2008) 1.06
Anaplasma phagocytophilum ligation to toll-like receptor (TLR) 2, but not to TLR4, activates macrophages for nuclear factor-kappa B nuclear translocation. J Infect Dis (2004) 1.06
Hepatic pathology in human monocytic ehrlichiosis. Ehrlichia chaffeensis infection. Am J Clin Pathol (2003) 1.06
Anaplasma phagocytophilum infection induces protracted neutrophil degranulation. Infect Immun (2004) 1.04
Multiplex 5' nuclease-quantitative PCR for diagnosis of relapsing fever in a large Tanzanian cohort. J Clin Microbiol (2011) 1.03
Human monocytic ehrlichiosis. JAMA (2004) 1.01
Fatal spotted fever rickettsiosis, Minas Gerais, Brazil. Emerg Infect Dis (2003) 1.00
Early induction and late abrogation of respiratory burst in A. phagocytophilum-infected neutrophils. Ann N Y Acad Sci (2003) 0.99
Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge model. Clin Infect Dis (2011) 0.98
Tick-borne agents in rodents, China, 2004-2006. Emerg Infect Dis (2009) 0.97
Chronic Q fever in the United States. J Clin Microbiol (2006) 0.95
Distribution of 'Ehrlichia walkeri' in Ixodes ricinus (Acari: Ixodidae) from the northern part of Italy. J Med Entomol (2005) 0.95
Defective phagocytosis in Anaplasma phagocytophilum-infected neutrophils. Infect Immun (2005) 0.95
Multiplex 5' nuclease quantitative real-time PCR for clinical diagnosis of malaria and species-level identification and epidemiologic evaluation of malaria-causing parasites, including Plasmodium knowlesi. J Clin Microbiol (2013) 0.93
Lyme borreliosis (Lyme disease): molecular and cellular pathobiology and prospects for prevention, diagnosis and treatment. Expert Rev Mol Med (2004) 0.93
Anaplasma phagocytophilum-Borrelia burgdorferi coinfection enhances chemokine, cytokine, and matrix metalloprotease expression by human brain microvascular endothelial cells. Clin Vaccine Immunol (2007) 0.93
Diagnosis of Wihipple disease by immunohistochemical analysis: a sensitive and specific method for the detection of Tropheryma whipplei (the Whipple bacillus) in paraffin-embedded tissue. Am J Clin Pathol (2002) 0.93
Differential innate immune cell activation and proinflammatory response in Anaplasma phagocytophilum infection. Infect Immun (2007) 0.92
The serological response of patients infected with the agent of human granulocytic ehrlichiosis. Clin Infect Dis (2001) 0.92
Innate immune response to Anaplasma phagocytophilum contributes to hepatic injury. Clin Vaccine Immunol (2006) 0.92
Unsuspected rickettsioses among patients with acute febrile illness, Sri Lanka, 2007. Emerg Infect Dis (2012) 0.91
Using detergent to enhance detection sensitivity of African trypanosomes in human CSF and blood by loop-mediated isothermal amplification (LAMP). PLoS Negl Trop Dis (2011) 0.91
Role of reactive nitrogen species in development of hepatic injury in a C57bl/6 mouse model of human granulocytic anaplasmosis. Comp Med (2006) 0.91
State of the art of diagnosis of rickettsial diseases: the use of blood specimens for diagnosis of scrub typhus, spotted fever group rickettsiosis, and murine typhus. Curr Opin Infect Dis (2016) 0.90
A newly discovered Anaplasma phagocytophilum variant in rodents from southeastern China. Vector Borne Zoonotic Dis (2008) 0.90
Antibiotic susceptibilities of Anaplasma (Ehrlichia) phagocytophilum strains from various geographic areas in the United States. Antimicrob Agents Chemother (2003) 0.90
Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and Anaplasmosis - United States. MMWR Recomm Rep (2016) 0.90
Impairment of gamma interferon signaling in human neutrophils infected with Anaplasma phagocytophilum. Infect Immun (2009) 0.89
Protease activated receptor signaling is required for African trypanosome traversal of human brain microvascular endothelial cells. PLoS Negl Trop Dis (2009) 0.89
Sequential analysis of Anaplasma phagocytophilum msp2 transcription in murine and equine models of human granulocytic anaplasmosis. Clin Vaccine Immunol (2007) 0.88
Suspected cases of Neorickettsia-like organisms in Brazilian dogs. Ann N Y Acad Sci (2004) 0.87
Comparative strain analysis of Anaplasma phagocytophilum infection and clinical outcomes in a canine model of granulocytic anaplasmosis. Vector Borne Zoonotic Dis (2010) 0.86
Innate immune tissue injury and murine HGA: tissue injury in the murine model of granulocytic anaplasmosis relates to host innate immune response and not pathogen load. Ann N Y Acad Sci (2005) 0.86
Divergent interactions of Ehrlichia chaffeensis- and Anaplasma phagocytophilum-infected leukocytes with endothelial cell barriers. Infect Immun (2003) 0.86
Anaplasma phagocytophilum major surface protein-2 (Msp2) forms multimeric complexes in the bacterial membrane. FEMS Microbiol Lett (2003) 0.85
Lessons from Anaplasma phagocytophilum: chromatin remodeling by bacterial effectors. Infect Disord Drug Targets (2012) 0.85
Anaplasma phagocytophilum and Borrelia burgdorferi in rabbits from southeastern China. Vet Parasitol (2009) 0.85
Scientific evidence and best patient care practices should guide the ethics of Lyme disease activism. J Med Ethics (2010) 0.81
Comparison and characterization of granulocyte cell models for Anaplasma phagocytophilum infection. Pathog Dis (2013) 0.81
Culture and phenotypic characterization of a Wolbachia pipientis isolate. J Clin Microbiol (2003) 0.81
PCR-based survey of Anaplasma phagocytophilum in Portuguese ticks (Acari: Ixodidae). Vector Borne Zoonotic Dis (2008) 0.80
Detection of new bunyavirus RNA by reverse transcription-loop-mediated isothermal amplification. J Clin Microbiol (2013) 0.79
Serotyping isolates of Anaplasma phagocytophilum by using monoclonal antibodies. Clin Diagn Lab Immunol (2003) 0.79
Lymph node hemophagocytosis in rickettsial diseases: a pathogenetic role for CD8 T lymphocytes in human monocytic ehrlichiosis (HME)? BMC Infect Dis (2006) 0.78
Anaplasma phagocytophilum, interferon gamma production and Stat1 signaling. Microbiol Immunol (2013) 0.78
A role for the peripheral blood fibrocyte in leishmaniasis? Trends Parasitol (2004) 0.77
The role of CD8 T lymphocytes in rickettsial infections. Semin Immunopathol (2015) 0.77
Human granulocytic ehrlichiosis in Germany: evidence from serological studies, tick analyses, and a case of equine ehrlichiosis. Ann N Y Acad Sci (2003) 0.77
Simultaneous infection with Borrelia burgdorferi and human granulocytic ehrlichiosis. Pediatr Infect Dis J (2003) 0.77
A case of Sweet syndrome associated with human granulocytic anaplasmosis. Arch Dermatol (2005) 0.76
Immunodetection of Tropheryma whipplei in intestinal tissues from Dr. Whipple's 1907 patient. N Engl J Med (2003) 0.76
Anaplasma phagocytophilum infection reduces expression of phagocytosis-related receptors on neutrophils. Ann N Y Acad Sci (2005) 0.76
Anti-gene padlocks eliminate Escherichia coli based on their genotype. J Antimicrob Chemother (2007) 0.76
Short-term malaria reduction by single-dose azithromycin during mass drug administration for trachoma, Tanzania. Emerg Infect Dis (2014) 0.75
Retrospective clinical and molecular analysis of conditioned laboratory dogs (Canis familiaris) with serologic reactions to Ehrlichia canis, Borrelia burgdorferi, and Rickettsia rickettsii. J Am Assoc Lab Anim Sci (2008) 0.75
Neorickettsia helminthoeca in dog, Brazil. Emerg Infect Dis (2006) 0.75
Rickettsia and other intracellular bacteria: recent outbreaks, novel pathogens, emerging diseases, new tools, and outstanding discoveries. FEMS Immunol Med Microbiol (2011) 0.75